Smart Sand (NASDAQ:SND) reported quarterly losses of $(0.17) per share which met the analyst consensus estimate. This is a 88.89 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $34.50 million which beat the analyst consensus estimate of $27.15 million by 27.07 percent. This is a 47.38 percent increase over sales of $23.41 million the same period last year.
SVB Leerink Maintains Outperform on Viridian Therapeutics, Raises Price Target to $40
SVB Leerink analyst Mike Kratky maintains Viridian Therapeutics (NASDAQ:VRDN) with a Outperform and raises the price target from $32 to $40.
